Page last updated: 2024-08-22

acetylglucosamine and Hypertrophy, Left Ventricular

acetylglucosamine has been researched along with Hypertrophy, Left Ventricular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vlasselaers, D1
Ashrafian, H; Bonser, RS; Calvert, M; Contractor, H; Drury, NE; Freemantle, N; Frenneaux, M; Graham, TR; Green, D; Howell, NJ; Isackson, H; Mascaro, JG; Pagano, D; Quinn, DW; Ranasinghe, AM; Rooney, SJ; Williams, LK; Wilson, IC1

Trials

1 trial(s) available for acetylglucosamine and Hypertrophy, Left Ventricular

ArticleYear
Glucose-insulin-potassium reduces the incidence of low cardiac output episodes after aortic valve replacement for aortic stenosis in patients with left ventricular hypertrophy: results from the Hypertrophy, Insulin, Glucose, and Electrolytes (HINGE) trial
    Circulation, 2011, Jan-18, Volume: 123, Issue:2

    Topics: Acetylglucosamine; Aged; AMP-Activated Protein Kinases; Aortic Valve; Aortic Valve Stenosis; Cardiac Output, Low; Double-Blind Method; Female; Glucose; Heart Valve Prosthesis; Humans; Hypertrophy, Left Ventricular; Incidence; Insulin; Male; Middle Aged; Phosphatidylinositol 3-Kinases; Potassium; Proto-Oncogene Proteins c-akt; Risk Factors; Treatment Outcome

2011

Other Studies

1 other study(ies) available for acetylglucosamine and Hypertrophy, Left Ventricular

ArticleYear
Glucose-insulin-potassium: much more than enriched myocardial fuel.
    Circulation, 2011, Jan-18, Volume: 123, Issue:2

    Topics: Acetylglucosamine; AMP-Activated Protein Kinases; Aortic Valve Stenosis; Cardiac Output, Low; Glucose; Humans; Hypertrophy, Left Ventricular; Insulin; Myocardium; Phosphatidylinositol 3-Kinases; Potassium; Proto-Oncogene Proteins c-akt; Risk Factors

2011